Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
1.700
-0.400 (-19.05%)
Nov 16, 2026, 4:00 PM EST - Market closed

Aligos Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
31.0918.337135.781.35186.82
Short-Term Investments
-59.5419.94-44.483.92
Cash & Short-Term Investments
31.0977.8456.94135.7125.83190.73
Cash Growth
-68.62%36.71%-58.04%7.85%-34.03%-21.67%
Restricted Cash
0.650.110.110.070.120.16
Other Current Assets
2.944.915.095.317.613.53
Total Current Assets
34.6882.8662.14141.08133.55204.42
Property, Plant & Equipment
12.244.967.339.8212.5114.97
Long-Term Investments
-----15.11
Other Long-Term Assets
0.270.720.630.630.630.87
Total Assets
47.1988.5370.09151.53146.69235.37

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.213.982.572.524.743.02
Accrued Expenses
15.1513.5315.5616.8416.0425.39
Current Portion of Leases
1.243.733.463.243.142.91
Current Unearned Revenue
--0.151.319.217.64
Total Current Liabilities
19.621.2321.7423.9133.1338.96
Long-Term Leases
10.661.534.927.99.4311.55
Long-Term Unearned Revenue
----0.23-
Other Long-Term Liabilities
5.6212.2372.4127.64-0.13
Total Liabilities
35.8834.9999.0759.4542.7950.64

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.0100
Additional Paid-In Capital
699.47695.27588.58578.33502.61487.35
Retained Earnings
-688.61-642.2-618.01-486.8-399.12-303.07
Comprehensive Income & Other
0.440.470.450.550.40.45
Total Common Equity
11.3153.55-28.9792.08103.9184.73
Shareholders' Equity
11.3153.55-28.9792.08103.9184.73
Total Liabilities & Equity
47.1988.5370.09151.53146.69235.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
11.95.258.3811.1412.5714.46
Net Cash (Debt)
19.1972.5948.56124.57113.25176.28
Net Cash Growth
-79.37%49.48%-61.01%9.99%-35.75%-23.52%
Net Cash Per Share
1.847.347.7548.5966.31110.57
Filing Date Shares Outstanding
6.256.196.113.031.721.71
Total Common Shares Outstanding
6.256.183.8631.721.71
Working Capital
15.0861.6340.4117.18100.42165.47
Book Value Per Share
1.818.67-7.5030.6560.52108.18
Tangible Book Value
11.3153.55-28.9792.08103.9184.73
Tangible Book Value Per Share
1.818.67-7.5030.6560.52108.18
Machinery
-8.328.047.918.287.48
Construction In Progress
--000.020.02
Leasehold Improvements
-6.266.16.16.095.94
SEC Filings: 10-K · 10-Q